Commentary on "Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma." Choueiri TK, Lim ZD, Hirsch, MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM, Dana-Farber Cancer Institute, Boston, MA. Cancer 2010;116:5219-25

Stephen Boorjian

doi:10.1016/j.urolonc.2011.07.021

Commentary on "Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma." Choueiri TK, Lim ZD, Hirsch, MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM, Dana-Farber Cancer Institute, Boston, MA. Cancer 2010;116:5219-25

Stephen Boorjian

Urology

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	585-586
Number of pages	2
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	29
Issue number	5
DOIs	https://doi.org/10.1016/j.urolonc.2011.07.021
State	Published - Sep 2011

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.1016/j.urolonc.2011.07.021

Cite this

Boorjian, S. (2011). Commentary on "Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma." Choueiri TK, Lim ZD, Hirsch, MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM, Dana-Farber Cancer Institute, Boston, MA. Cancer 2010;116:5219-25. Urologic Oncology: Seminars and Original Investigations, 29(5), 585-586. https://doi.org/10.1016/j.urolonc.2011.07.021

Commentary on "Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma." Choueiri TK, Lim ZD, Hirsch, MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM, Dana-Farber Cancer Institute, Boston, MA. Cancer 2010;116:5219-25. / Boorjian, Stephen.
In: Urologic Oncology: Seminars and Original Investigations, Vol. 29, No. 5, 09.2011, p. 585-586.

Research output: Contribution to journal › Short survey › peer-review

Boorjian, S 2011, 'Commentary on "Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma." Choueiri TK, Lim ZD, Hirsch, MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM, Dana-Farber Cancer Institute, Boston, MA. Cancer 2010;116:5219-25', Urologic Oncology: Seminars and Original Investigations, vol. 29, no. 5, pp. 585-586. https://doi.org/10.1016/j.urolonc.2011.07.021

Boorjian S. Commentary on "Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma." Choueiri TK, Lim ZD, Hirsch, MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM, Dana-Farber Cancer Institute, Boston, MA. Cancer 2010;116:5219-25. Urologic Oncology: Seminars and Original Investigations. 2011 Sep;29(5):585-586. doi: 10.1016/j.urolonc.2011.07.021

Boorjian, Stephen. / Commentary on "Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma." Choueiri TK, Lim ZD, Hirsch, MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM, Dana-Farber Cancer Institute, Boston, MA. Cancer 2010;116:5219-25. In: Urologic Oncology: Seminars and Original Investigations. 2011 ; Vol. 29, No. 5. pp. 585-586.

@article{9061f54dc2fd40ac8026053c28200bd8,

title = "Commentary on {"}Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma.{"} Choueiri TK, Lim ZD, Hirsch, MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM, Dana-Farber Cancer Institute, Boston, MA. Cancer 2010;116:5219-25",

author = "Stephen Boorjian",

year = "2011",

month = sep,

doi = "10.1016/j.urolonc.2011.07.021",

language = "English (US)",

volume = "29",

pages = "585--586",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Commentary on "Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma." Choueiri TK, Lim ZD, Hirsch, MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM, Dana-Farber Cancer Institute, Boston, MA. Cancer 2010;116:5219-25

AU - Boorjian, Stephen

PY - 2011/9

Y1 - 2011/9

UR - http://www.scopus.com/inward/record.url?scp=80052937157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052937157&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2011.07.021

DO - 10.1016/j.urolonc.2011.07.021

M3 - Short survey

AN - SCOPUS:80052937157

SN - 1078-1439

VL - 29

SP - 585

EP - 586

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 5

ER -

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this